Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 99

Comparing two types of steroids for sacroiliac joint injections

Official title: Particulate Versus Non-Particulate Corticosteroid in Sacroiliac Joint Injection: A Randomized Prospective Study

Run by University of New Mexico · NCT06268704 · Data updated 2026-11-12

This study is testing which of two steroids, dexamethasone or methylprednisolone, works better to relieve pain for people with sacroiliac joint issues after receiving injections.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment230 (estimated)
SponsorUniversity of New Mexico
Academic / other
Locations1 site (Albuquerque, New Mexico)
StatusRecruiting
StartedMarch 27, 2024
Main results expectedJanuary 1, 2027
Study endsMay 1, 2027
Registry record updatedNovember 6, 2025
Trial IDNCT06268704 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with unilateral low back or buttocks pain lasting at least two weeks and a significant pain rating.

Probably not a fit

Patients with conditions unrelated to sacroiliac joint dysfunction or those who cannot comply with the study requirements may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the efficacy and safety of two corticosteroids, dexamethasone and methylprednisolone, in treating sacroiliac joint pain through injections. Patients will be randomly assigned to receive one of the two medications and will report their pain levels immediately after the procedure. They will be monitored for three months to assess the outcomes of pain relief and any potential side effects. The goal is to determine which steroid provides better relief for patients suffering from sacroiliac joint dysfunction.

Why it matters

Potential benefit: If successful, this study could lead to more effective treatment options for patients with sacroiliac joint pain.

How similar studies have gone: Other studies have explored corticosteroid injections for joint pain, but this specific comparison of dexamethasone and methylprednisolone is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged \>18, capable of understanding and providing consent in English, capable of complying with the outcome instruments used, capable of attending all planned follow up visits
* Unilateral low back/buttocks pain of at least 2 weeks.
* Patient reported 7 day average of numeric pain rating score (NPRS) low back/buttocks pain of at least 5/10 at baseline evaluation
* Clinical diagnosis of sacroiliac joint pain as diagnosed by a board certified Physiatrist including history of low back/buttocks pain and at least 2 positive physical exam findings (including positive fortin finger sign, pain with palpation of posterior superior iliac spine, positive FABER's test, positive Gaenslan's test, positive sacral distraction, positive thigh thrust, positive lateral compression, positive sacral thrust)
* Patient consents to sacroiliac joint corticosteroid injection in a shared decision-making process with the treating physician.
* 80% or more relief of index pain within first 5-15 minutes after injection

Exclusion Criteria:

* Clinical suspicion of alternative process is greater than clinical suspicion of sacroiliac joint pain
* Those receiving remuneration for their pain treatment (e.g., disability, worker's compensation).
* Those involved in active litigation relevant to their pain.
* Those unable to read English and complete the assessment instruments.
* Those unable to attend follow up appointments
* The patient is incarcerated.
* History of prior sacroiliac joint fusion
* Progressive lower extremity neurologic deficit (from active radiculopathy, unhealed radiculopathy, or neuromuscular disease)
* Sacroiliac joint steroid injection within the prior 12 months
* 2 Positive lumbar medial branch blocks within the past 12 months
* Radiofrequency ablation of the lumbar spine within the past 12 months
* Lumbar facet steroid injections within the past 12 months
* Prior epidural steroid injection within the prior 3 months in any location within the spine.
* Possible pregnancy or other reason that precludes the use of fluoroscopy.
* Allergy to steroid, contrast media, or local anesthetics.
* BMI\>40.
* Systemic inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis, lupus).
* Active infection or treatment of infection with antibiotics within the past 7 days.
* Medical conditions causing significant functional disability (e.g., stroke, decompensated ---COPD, decompensated heart failure)
* Chronic widespread pain or somatoform disorder (e.g. fibromyalgia).
* Addictive behavior, severe clinical depression, or psychotic features.

Where it's running

  • University of New Mexico Hospital
    Albuquerque, New Mexico, United States
    Recruiting

Study contacts

  • Principal investigator: Reza Ehsanian, MD, PhD — University of New Mexico Department of Anesthesiology and Critical Care
  • Study coordinator: Mark W Shilling, BS
  • Email: mwshilling@salud.unm.edu
  • Phone: 505-925-7599

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.